EUVIMEDEUVIMED entdecken
Crossref

Development of Amoxicillin-Loaded Modified Polycaprolactone Microparticles in Medical Application

Chalita Metheeparakornchai, Narumol Kreua-ongarjnukool, Saowapa Thumsing Niyomthai, Prasit Pavasant, Chalida Nakalekha Limjeerajarus

International Journal of Pharma Medicine and Biological Sciences · 2021

DOI: 10.18178/ijpmbs.10.2.88-93 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharma Medicine and Biological Sciences, 2021. Verfasst von Chalita Metheeparakornchai und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amoxicillin is realized as significant drug due to their essential inhibition of bacterial infections. However, the effective time of amoxicillin in clinical position is less than 8 hours. Therefore, this research was to prolong the drug delivery system. Chitosan was modified by PCL (PCL/CS) microparticles were fabricated by oil in water emulsion (o/w emulsion) techniques for the protection and controlled the release of amoxicillin. The ratio of PCL: chitosan at different ratios were investigated for their influences on the zeta potential, size, morphology, swelling ratio and the release rate of amoxicillin from PCL/CS microparticles. The encapsulation efficiency was 74% to 83% and the maximum cumulative released amounts of amoxicillin from the PCL/CS at ratio 1:5 was about 6.5±0.03 mg for 7 days. Furthermore, the antimicrobial of amoxicillin was demonstrated by antimicrobial activity assays, which are effective in treating Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus). The PCL/CS was enough for the bacterial inhibition growth of E. coli and S. aureus. The PCL/CS could be appropriate to supply a model the drug delivery system for the medical application.

Zitieren

APA

Metheeparakornchai, C., Kreua-ongarjnukool, N., Niyomthai, S. T., Pavasant, P., & Limjeerajarus, C. N. (2021). Development of Amoxicillin-Loaded Modified Polycaprolactone Microparticles in Medical Application. International Journal of Pharma Medicine and Biological Sciences. https://doi.org/10.18178/ijpmbs.10.2.88-93

Vancouver

Metheeparakornchai C, Kreua-ongarjnukool N, Niyomthai ST, Pavasant P, Limjeerajarus CN. Development of Amoxicillin-Loaded Modified Polycaprolactone Microparticles in Medical Application. International Journal of Pharma Medicine and Biological Sciences. 2021. doi:10.18178/ijpmbs.10.2.88-93

BibTeX
@article{Metheeparakornchai2021,
  author = {Metheeparakornchai, Chalita and Kreua-ongarjnukool, Narumol and Niyomthai, Saowapa Thumsing and Pavasant, Prasit and Limjeerajarus, Chalida Nakalekha},
  title = {Development of Amoxicillin-Loaded Modified Polycaprolactone Microparticles in Medical Application},
  journal = {International Journal of Pharma Medicine and Biological Sciences},
  year = {2021},
  doi = {10.18178/ijpmbs.10.2.88-93}
}
Kostenlos starten →